Measurement of apolipoproteins AI, B and atherogenic risk in homozygous sickle cell disease;Évaluation du risque athérogène chez le drépanocytaire homozygote: Étude des taux plasmatiques des lipides et apolipoprotéines AI et B

Bulletin de la Societe de Pathologie Exotique

Volumn 89, Issue 4, 1996, Pages 278-281

  Monnet, D ^a,b   Kane, F ^a,b   Konan Waidhet, D ^a,b   Akpona, S ^d   Kora, J ^d   Diafouka, F ^a,b   Sess, D ^c   Sangare, A ^c   Yapo, A E ^a,b  

^a Faculte de Pharmacie   (Côte d’Ivoire)

^b INSTITUT PASTEUR DE CÔTE D'IVOIRE   (Côte d’Ivoire)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE YOPOUGON   (Côte d’Ivoire)

^d UER de Biochimie   (Benin)

Author keywords

Apo AI; Apo B; Atherogenic risk; Cote d'Ivoire; Homozygous sickle cell disease

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; LIPID;

ADOLESCENT; ADULT; ARTERIOSCLEROSIS; ARTICLE; BLOOD; CASE CONTROL STUDY; CHILD; COTE D'IVOIRE; FEMALE; HUMAN; PRESCHOOL CHILD; RISK FACTOR; SICKLE CELL ANEMIA;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; ARTERIOSCLEROSIS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COTE D'IVOIRE; FEMALE; HUMANS; LIPIDS; RISK FACTORS;

EID: 0030332105     PISSN: 00379085     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. AVOGARO (P.), BlTTOLO (B. G.), CAZZOLATO (G.), QUINCI (G. B.) & BELUSSI (F.). - Plasma levels of apolipoprotein AI and apolipoprotein B in human atherosclerosis. Artery, 1978, 4, 385-394.
2. BENDITT (E. P.) & ERIKSEN (N.). - Amyloid protein SAA is associated with high density lipoproteins from human serum. Proc. Natl. Acad. Sci. USA, 1977, 74, 4025-4031.
3. BERRERAS (L.), DIGGS (L. W.) & LIPSCOMB (A.). -Plasma volume in sickle cell disease. South Med. J., 1966, 59, 456-458.
4. BLAVY (G.), LAURENS (A.), LINHARD (J.) & SOULA (G.). - Lipides et protéines sériques dans la drépanocytose du Sénégalais. Bull. Soc. Méd Afr. Noire Langue française, 1978, 23, 355-360.
5. BIENVENU (J.). - Les protéines de la réaction inflammatoire. Définition, physiologie et méthodes de dosage. Ann. Biol. Clin., 1984, 42, 53-59.
6. CABANNES (R.), SENDRAIL (A.), PENE (F.), SANGARE (A.), SOMBO (M. F.) & KPLE (F. P.). - Etude de l'hémotypologie des populations de l'Afrique de l'ouest. Référence particulière aux populations ivoiriennes et aux peulhs. Ann. Univ. Abidjan, 1979, Série B, 13, 105-135.
7. CANO (M. D.), GONZALVO (C.), SCHEEN (A. J.) & CASTILLO (M. J.). - Measurement of apolipoproteins B and A by radial immunodiffusion: methodological assessment and clinical applications. Ann. Biol. Clin., 1994, 52, 657-661.
8. DEELEY (R. G.), TAM (S. P.) & ARCHER (T.). - The effects of oestrogen on apolipoprotein synthesis. Can. J Biochem. Cell. Biol., 1985, 63, 882-889.
9. DESOYE (G.), SEHWEDITSCH (M. O.), PFEIFFER (K. P.), SECHNER (R.) & KOSTNER (G. M.). - Correlation of hormones with lipid and lipoprotein levels during normal pregnancy and post partum. J. Clin. Endocrin. Metab., 1987, 64, 704-712.
10. DJOUMESSI (S.), ZEKENG (G.), LANDO (G.) & ZEU-KENG (D.). - Serum lipids and atherogenic risk in sickle-cell trait carriers. Ann. Biol. Clin., 1994, 52, 663-665.
11. EL-HAZMI (M. A. F.), JABBAR (F. A.) & WARSY (A. S.). - Cholesterol and triglyceride level in patients with sickle cell anaemia. Scand. J. Clin. Lab. Invest., 1987, 47, 351-354.
12. ERASMUS (R. T.), OLUKOGA (A. O.) & OJUAWO (O.). -Plasma lipids and lipoproteins in Nigerian children with sickle-cell anaemia. Ann. Tropical Paediatrics, 1990, 10, 421-423.
13. HEBBEL (R. P.), EATON (J. W.), BALASINGAM (M.) & STEINBER (M. H.). - Spontaneous oxygen radical gene-ration by sickle erythrocytes. J. Clin. Invest., 1982, 70, 1253-1259.
14. JAIN (S. K.), Ross (J. D.), LEVY (G. J.), LITTLE (R. L.) & DUETT (J.). - The accumulation of malonyldialdehyde, an end product of membrane lipid peroxidation, can cause potassium leak in normal and sickle red blood cells. Biochem. Med. Metab. Biol., 1989, 42, 60-65.
15. JENKINS (M. E.), SCOTT (R. B.) & FERGUSON (A. D.). -Studies in sickle cell anaemia. Blood volume relationship and the use of plasma extender in sickle cell disease in childhood: a preliminary report. Pediatrics, 1956, 18, 239-447.
16. MAZURKIEWICZ (J. C.), WATTS (G. F.), WARBURTON (F. G.), SIAVIN (B. M.), LEWY (C.) & KOUKKOU (E.). -Serum lipids, lipoproteins and apolipoproteins in pregnant non diabetic patients. J. Clin. Pathol., 1994, 47, 728-731.
17. 1-grycoprotéine acide et de la transferrine au cours de la drépanocytose homozygote. Bull. Soc. Path. Ex., 1993, 86, 282-285.
18. PARTHASARATHY (S.), PRINTZ (D. J.), BOYD (D.), JOY (L.) & STEINBERG (D.). - Macrophage oxydation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis, 1986, 6, 505-507.
19. PECH (M. A.), MYARA (J.), VEDIE (B.) & MOATTI (N.). -Modified LDL and atherosclerosis. Nature of modification. Physicochemical and biological properties. Ann. Biol. Clin., 1992, 50, 213-227.
20. RICE-EVANs (C.), OMORPHOS (S. C.) & BAYSAL (E.). -Sickle cell membranes and oxidative damage. Biochem. J., 1986, 237, 265-269.
21. ROSENFIELD (L.). - Atherosclerosis and cholesterol connection. Evolution of a clinical application. Clin. Chem., 1989, 35, 521-531.
22. SAILE (R.) & FRUCHART (J. C.). - L'apolipoprotéine sérique amyloïde A (Apo SAA). Implication dans l'inflammation et dans les modifications des lipoprotéines. Ann. Biol. Clin., 1990, 48, 77-85.
23. SASAKI (J.), WATERMAN (M. R.), BUCHANAN (G. R.) & COTTAM (G. L.). - Plasma and erythrocyte lipids in sickle cell anaemia. Clin. Lab. Haematol., 1983, 5, 35-44.
24. SESS (D.), CARBONNEAU (M. A.), THOMAS (M. J.), DUMON (M. F.), PEUCHANT (E.), PERROMAT (A.), LE BRAS (M.) & CLERC (M.). - Premières observations sur les principaux paramètres plasmatiques du stress oxydatif chez le drépanocytaire homozygote. Bull. Soc. Path. Ex., 1992, 85, 174-179.
25. STEINBRECHER (U. P.), WITZTUM (J. L.), PARTHASARATHY (S.) & STEINBERG (G. D.). - Decrease in reactive amino-groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis, 1987, 7, 135-138.
26. WALD (N. J.), LAW (M.), WATT (C. H.), WU (T.), BAILEY (A.), JONHSON (A. M.), CRAIG (W. Y.), LEDUE (T. B.) & HADDOW (J. E.). - Apolipoproteins and ischaemic heart disease: implications for screening. The Lancet, 1994, 343, 75-79.
27. WAYNE (T. F.), ALAUPOVIC (P.), CURRY (M. D.), LU (G.), ANDERSON (P. S.) & SCHECTIN (E.). - Plasma apolipoprotein B and VLDL-, LDL-, HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography. Atherosclerosis, 1981, 39, 411-424.
28. YAPO (A. E.), ASSAYI (M.), AKA (N. B.), BONETTO (R.), COMOE (L.), LONSDORFER (A.), MONNET (D.) & DIAINE (C.). - Les valeurs de références de 21 constituants biochimiques sanguins de l'Ivoirien adulte présumé sain. Pub. Méd. Afr., 1990, 110, 49-57.